JB Chemicals Financial Statements

JB Chemicals (JBCHEPHARM) reported revenue of ₹39.18B in FY2025 with net income of ₹6.60B. Total assets stood at ₹42.74B and free cash flow was ₹8.05B.

JB Chemicals Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		20.43B	24.63B	31.59B	35.21B	39.18B
Cost of Rev. Cost of Revenue		-7.01B	-8.43B	-11.68B	-11.82B	-13.17B
Gross Profit		13.41B	16.21B	19.91B	23.39B	26.01B
SGA Sales, General & Admin		-7.81B	-10.38B	-12.85B	-14.05B	-6.88B
Op. Income Operating Income		4.92B	5.10B	5.91B	7.96B	8.61B
PBT Profit Before Tax		5.97B	5.05B	5.55B	7.52B	8.87B
Net Income		4.48B	3.86B	4.10B	5.53B	6.60B
Dil. Shares Diluted Shares		154.56M	154.71M	156.62M	158.59M	158.69M
Diluted EPS		28.98	24.91	26.17	34.85	41.56

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows JB Chemicals's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

JB Chemicals Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		15.53B	12.53B	15.28B	18.53B	19.23B
Non-curr. assets Total non-current assets		6.86B	13.54B	20.26B	21.41B	23.51B
Total assets		22.38B	26.07B	35.54B	39.94B	42.74B
Curr. liabilities Total current liabilities		3.45B	3.84B	5.54B	8.68B	6.32B
Non-curr. liab. Total non-current liabilities		794.12M	850.74M	5.19B	2.03B	2.08B
Total liabilities		4.25B	4.69B	10.74B	10.71B	8.40B
Total equity		18.13B	21.39B	24.80B	29.23B	34.33B
Total liab. & eq. Total liabilities & equity		22.38B	26.07B	35.54B	39.94B	42.74B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures JB Chemicals's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

JB Chemicals Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		5.97B	5.05B	5.55B	7.52B	8.87B
Operating CF Cash flow Operating Activities		3.15B	1.70B	6.26B	8.01B	9.02B
Capex Investments in PPE		-477.73M	-628.70M	-725.69M	-1.27B	-975.88M
Investing CF Cash flow Investing Activities		-2.31B	23.20M	-9.62B	-4.04B	-2.96B
Dividend Paid		0	-1.28B	-1.28B	-1.57B	-2.37B
Financing CF Cash flow Financing Activities		-874.23M	-1.38B	3.57B	-3.85B	-5.80B
Cash (start) Cash at beginning of period		257.52M	224.74M	565.44M	769.34M	882.15M
Cash (end) Cash at end of period		224.74M	565.44M	769.34M	882.15M	1.15B
FCF Free Cash Flow		2.67B	1.07B	5.53B	6.74B	8.05B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how JB Chemicals's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025